We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sloning BioTechnology Starting Feasibility Study to Improve the Efficiency of an Enzyme Used in Molecular Diagnostic Applications for bioMérieux.

News   Aug 14, 2007

 
Sloning BioTechnology Starting Feasibility Study to Improve the Efficiency of an Enzyme Used in Molecular Diagnostic Applications for bioMérieux.
 
 
 

RELATED ARTICLES

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

READ MORE

1 in 4 Statisticians Asked to Commit Scientific Fraud

News

A stunning report concludes that researchers often ask statisticians to make "inappropriate requests." Not accidental requests for incorrect statistical analyses; but unscrupulous data manipulation or even fraud.

READ MORE

BASF licenses CRISPR-Cpf1 from the Broad Institute of MIT and Harvard

News

The chemical company BASF has attained a global, non-exclusive licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 genome editing technology to improve products in agricultural and industrial microbiology applications.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE